Insider sale
CONNECT BIOPHARMA HOLDINGS LTD
$1.02M
702.49K shares
What this filing means
RA CAPITAL NEXUS FUND, L.P. plans to sell 702.49K shares of CONNECT BIOPHARMA HOLDINGS LTD valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/27/2023ACC: 0001178937-23-000031
702.49K
Shares to sell
$1.02M
Approx. market value
151.78K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
IPO Investment
Cash
3/19/2021
11.36KPrivate Placement
Cash
8/21/2020
140.42KTotal acquired151.78K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/19/2021 | IPO Investment Cash | 11.36K | — |
8/21/2020 | Private Placement Cash | 140.42K | — |
| Total | 151.78K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
19.47K
Market value
$25.4K
11/22/2023
—Completed
Units to sell
116.31K
Market value
$151.9K
11/22/2023
—Completed
Units to sell
355.42K
Market value
$556.9K
11/21/2023
—Completed
Units to sell
59.51K
Market value
$93.2K
11/21/2023
Planned — Approximate Date
NasdaqPlanned
Units to sell
151.78K
Market value
$195.8K
11/27/2023
Total
Units
702.49K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/22/2023 | 19.47K | $25.4K | — | Completed |
11/22/2023 | 116.31K | $151.9K | — | Completed |
11/21/2023 | 355.42K | $556.9K | — | Completed |
11/21/2023 | 59.51K | $93.2K | — | Completed |
| Planned — Approximate Date | ||||
11/27/2023 | 151.78K | $195.8K | Nasdaq | Planned |
| Total | 702.49K | $1.02M | ||